Starlake Bioscience Co Inc Zhaoqing Guangdong (600866)

Currency in CNY
5.01
-0.03(-0.60%)
Closed·
Advertisement
600866 is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
4.955.10
52 wk Range
4.268.55
Key Statistics
Bid/Ask
5.00 / 5.01
Prev. Close
5.04
Open
5.03
Day's Range
4.95-5.1
52 wk Range
4.26-8.55
Volume
29.9M
Average Volume (3m)
23.39M
1-Year Change
-33.1108%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
600866 Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
8.96
Upside
+78.84%
Members' Sentiments
Bearish
Bullish
ProTips
Significant return over the last week
Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Buy

Analyst Ratings

1 Buy
0 Hold
0 Sell
Ratings:
1 analysts
Overall Consensus
Strong Buy

Analysts 12-Month Price Target:

Average 8.96
(+78.84% Upside)

Earnings

Latest Release
30/04/2026
EPS / Forecast
-0.03 / --
Revenue / Forecast
3.74B / --
EPS Revisions
Last 90 days

Compare 600866 to Peers and Sector

Metrics to compare
600866
Peers
Sector
Relationship
P/E Ratio
18.1x18.4x11.5x
PEG Ratio
−0.30−0.450.03
Price/Book
1.0x1.8x1.5x
Price / LTM Sales
0.5x1.2x0.9x
Upside (Analyst Target)
78.8%34.7%24.5%
Fair Value Upside
Unlock30.2%14.0%Unlock

Star Lake Bioscience Co., Inc.Zhaoqing Guangdong engages in the manufacture and selling food additives, feed additives, pharmaceutical intermediates, active pharmaceutical ingredients, organic fertilizers, and bio-based new materials. It operates through three main business lines: food and feed additives, biochemical raw materials and pharmaceutical intermediates, and organic fertilizers. The company offers food additives, including monosodium glutamate, nucleotides, compound seasonings, and corn fermentation products; feed additives such as lysine, threonine, valine, isoleucine, tryptophan, and arginine; pharmaceutical intermediates and active pharmaceutical ingredients including inosine, ribavirin, proline, guanosine, adenosine, adenine, as well as intermediates for AIDS and hepatitis C drugs; and other products, such as organic fertilizers and bio-based materials. The company also provides research, development, and production services in bio-fermentation and chemical synthesis; and engages in the construction and operation of corn deep processing and amino acid projects. In addition, the company offers disodium 5’-guanylate for canned and salted meat, ham, etc. Further, it provides ribavirin, adenosine, adenine, memantine hydrochloride, arginine, D-ribose, fructose syrup, L-valine, L-threonine, L-lysine, etc. Star Lake Bioscience Co., Inc.Zhaoqing Guangdong was founded in 1964 and is based in Zhaoqing, China.

Employees
10528
Market
China

Ownership

Ownership Overview

Type
Common Stock Held% of Shares OutstandingMarket Value
Mutual Funds & ETFs
82.17M4.95%400.19M
Other Institutional Investors
746.67M44.94%3.64B
Public Companies & Retail Investors
832.63M50.11%4.05B
Total
1.66B100.00%8.09B

Top Holders

Holder
% of holding
Shares Held
Date Reported
Value (In 1,000s)
Guangdong Guangxin Holdings Group Ltd.34.09%566,427,4872,758,502
Ningxia Yipin Investment Group Co., Ltd.10.00%166,147,329809,137

People Also Watch

9.04
002096
-1.42%
4.79
600517
-0.42%
12.09
600216
-3.97%
8.46
600109
-1.51%

FAQ

What Is the Starlake Bioscience (Shanghai: 600866) Share Price Today?

The Starlake Bioscience stock price today is 5.01 CNY.

What Stock Exchange Does Starlake Bioscience (600866) Trade On?

Starlake Bioscience is listed and trades on the Shanghai Stock Exchange.

What Is the Ticker (Stock Symbol) for Starlake Bioscience?

The stock symbol (also called a 'ticker') for Starlake Bioscience is "600866."

What Is the Current Starlake Bioscience Market Capitalisation?

As of today, Starlake Bioscience (Shanghai: 600866) market cap is 8.32B CNY.

What Is Starlake Bioscience's (600866) Earnings Per Share (TTM)?

The Starlake Bioscience EPS is currently 0.28 (Trailing Twelve Months).

When Is the Next Starlake Bioscience Earnings Date?

Starlake Bioscience's next earnings report will be released on 20/08/2026.

Is 600866 a Buy or Sell From a Technical Analyst Perspective?

Based on today's Starlake Bioscience moving averages and other technical indicators, the daily buy/sell signal for 600866 stock is Strong Buy.

How Many Times Has Starlake Bioscience Stock Split?

Starlake Bioscience has split 5 times. (See the 600866 stock split history page for full effective split date and price information.)

How Many Employees Does Starlake Bioscience Have?

Starlake Bioscience has 10528 employees, based on their latest Companies House report.

What is the current trading status of Starlake Bioscience (Shanghai: 600866)?

As of 18/07/2026, Starlake Bioscience (600866) is trading at a share price of 5.01 CNY, with a previous close of 5.04 CNY. The stock has fluctuated within a day range of 4.95 CNY to 5.10 CNY, while its 52-week range spans from 4.26 CNY to 8.55 CNY.

What Is Starlake Bioscience (600866) Price Target According to Analysts?

The average 12-month price target for Starlake Bioscience is 8.96 CNY, with a high estimate of 8.96 CNY and a low estimate of 8.96 CNY. 1 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Strong Buy. The stock has an +78.84% Upside potential.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.